GLP-1 Exit · Deprescribing · Clinical Data Review · Metabolic Health

On medication and thinking about what comes next? Clinician-led plans for what happens after the prescription.

Starting is easy. Coming off well is the part no one explains.

NHS A&E doctor with a clinical focus in deprescribing, GLP-1 exit strategy, metabolic health, and clinical data review. Built around clinical judgement — not ideology, not trends.

On a GLP-1 and unsure what happens when you stop
On multiple medications and want one coherent clinical plan
Accumulating health data with no qualified interpretation
Stopped medication and weight is already returning

Book or request a call How it works →

Medication changes should always be individual, clinically reviewed, and coordinated with your usual doctor where appropriate.

Clinical appointments via CQC-registered Sutton Medical Consulting

Dr Dan Reardon — NHS A&E doctor and deprescribing specialist

Core Services

Four clinical pathways. One clinician.

Each service is a distinct clinical offering. All four sit under Dr Dan Reardon and are delivered via CQC-registered Sutton Medical Consulting.

Flagship

GLP-1 Exit Strategy

Mounjaro · Wegovy · Ozempic

Clinician-led plan for tapering or stopping GLP-1 medication. Covers appetite return, muscle loss, weight regain risk, monitoring strategy, and a written exit plan. The most evidenced-backed exit protocol available privately in the UK.

From £445 · 60-minute review · Video available

View service →

Deprescribing

SSRIs · PPIs · Statins · Blood pressure medication · Polypharmacy

Medication review and stepwise deprescribing plans. Built around your risk profile — not a template. Covers GLP-1s, SSRIs, PPIs, statins, blood pressure medication, and polypharmacy loads that haven't been reviewed in years.

From £395 · 60-minute review

View service →

Clinical Data Review

Blood tests · Wearables · CGM · DNA · Private labs

You have data from Medichecks, Thriva, Zoe, a CGM, or a wearable. What does it actually mean? Expert clinical interpretation of your results with a written plan for what to do next. AI can pattern-match. This is clinical judgement.

£395 · 45-minute review · Video available

View service →

Independent Medication Review

For patients and families

A comprehensive independent clinical assessment of a patient's full medication history. Every drug reviewed for current appropriateness, interactions, and whether the original indication still applies. Delivered as a structured written report. Can be initiated by a family member.

£1,200 · Fixed fee · Two appointments + written report

View service →

Deprescribing Pathways

Choose your starting point.

Each medication class has a different rebound pattern and taper strategy. The plan is built for your pathway.

GLP-1 Exit Strategy

Wegovy · Ozempic · Mounjaro

Clinician-led plan to maintain results through appetite return, lean mass protection, and long-term maintenance.

View pathway →

SSRI / Antidepressant Review

Sertraline · Fluoxetine · Citalopram

Careful taper planning with stability scaffolding across sleep, stress load, and relapse prevention.

View pathway →

PPI Review

Reflux medications

Rebound reflux planning, dietary trigger identification, step-down strategies, and lifestyle levers.

View pathway →

Statin Review

Where appropriate

Risk stratification and shared decision-making to confirm whether ongoing therapy remains clinically indicated.

View pathway →

Blood Pressure Medication

Step-down with home monitoring

If readings are stable, we review whether medication is still needed and plan a safe, monitored step-down.

View pathway →

Levothyroxine Review

Do you really need it

Was the original indication clinically justified, is a question very few patients have ever been invited to ask.

View pathway →

Medication Load Review

Polypharmacy

On multiple medications? One coherent, clinician-led plan — mapping the full regimen, interactions, and priorities.

View pathway →

Clinical Process

Deprescribing is the easy part.

Staying stable afterwards is the work. Here is how it is done.

Assess

Stabilise

Plan

Taper / Adjust

Maintain

Review your history, goals, current medication list, and previous attempts. Map the likely rebound points and define what success looks like for you.

Before changing anything, build a stable baseline: nutrition structure, strength plan, sleep anchors, and symptom tracking. This reduces noise.

A personalised plan: what to continue, what to adjust, what may be reduced. Clear monitoring targets and check-in points. Written and yours to keep.

Step-down is gradual and responsive, with symptom tracking and decision rules. Coordinated with your GP or specialist where needed.

Locking in maintenance: habits, environment design, relapse prevention, and follow-up. Stability without white-knuckling.

Assess

Review your history, goals, current medication list, and previous attempts.

Stabilise

Build a stable baseline: nutrition, sleep, symptom tracking — before changing anything.

Plan

A personalised written plan with clear monitoring targets and check-in points.

Taper / Adjust

Gradual, responsive step-down with symptom tracking and decision rules.

Maintain

Habits, environment design, relapse prevention, and follow-up locked in.

Medication changes are always individual and should never be done abruptly without clinical supervision.

Patient Fit

If any of these describe you, this clinic is built for you.

The patients who book are not looking for motivation. They want clinical specificity and a plan that holds.

GLP-1 continuation or exit

On Mounjaro, Wegovy, or Ozempic and planning to stop — or already stopped and watching weight return. A medically supervised plan for what comes next.

Rebound appetite and early regain

Hunger, cravings, or weight returning after stopping medication. Stabilise the baseline, implement a structured transition plan, and manage the highest-risk window clinically.

Polypharmacy & medication load

On multiple medications — some for decades — with no recent review. One coherent, clinician-led plan with interactions mapped and priorities clear.

Private health data with no interpretation

Using Medichecks, Thriva, Zoe, a CGM, or wearables and accumulating results without qualified clinical interpretation. The data is only useful when someone can tell you what it means.

High-performance and longevity focus

Into strength, longevity, and optimisation. Wants the clinical edge — a comprehensive metabolic audit with a goal-aligned written report. The premium offering for patients who want everything assessed properly.

Family-initiated medication review

Concerned about a relative's medication load — particularly an elderly parent on a long and unreviewed prescription list. The Independent Medication Review can be initiated by a family member with patient consent.

Clinical Lead

Dr Dan Reardon

NHS A&E Doctor · Deprescribing Specialist · Metabolic Physician

NHS A&E DoctorFrontline emergency medicine · active

MB ChB · BSc · MScCardiff & Birmingham

GMC 6098984Fully registered

Former FitnessGenes CEO$10M+ venture-backed · 3,000+ data reviews

Chief Medical AdvisorGoodnick

Former Science EditorMuscle & Fitness Magazine

CQC-Registered PracticeVia Sutton Medical Consulting

Former Medical AdviserCambridge Weight Plan 1:1

Featured In & Spoken At

New York Times · Scientific American · GQ · Daily Telegraph · LA Times · NBC The Doctors · ABC News · BBC Radio London · Talk Radio · Bulletproof Biohacking Conference · Health 2.0 · BuzzFeed · GCN

I continue to work in NHS A&E. That shapes everything I do in private practice. Frontline emergency medicine gives you a precise understanding of what happens when medication management goes wrong — and what it looks like when it goes right.

Deprescribing isn't the hard part. Staying stable afterwards is. That's what I build for — not ideology, not trends, not abrupt discontinuation. A clinician-led plan with monitoring, contingencies, and a maintenance system that holds.

Trusted by high performers.

Grounded in clinical judgement.

"I've been in media since I was 18, and I've watched every health and fitness craze come and go. For 20 years, Dan has been the constant — consistent, credible, and cutting-edge. Long before 'lifestyle medicine' had a name, he was championing longevity with a muscle-first approach we now know is essential."

Andi Peters

British TV presenter, producer, and voice actor

"Dan is a rare find. He hasn't just studied fitness, nutrition, and supplementation — he's lived it for nearly 30 years. Add the clinical judgement of an emergency doctor and you get lifestyle medicine at a different level: non-judgemental, deeply engaged, and unafraid to challenge the consensus when it counts."

Nick Mitchell

Founder, Ultimate Performance

"What sets Dan apart is how he combines elite performance knowledge with a nuanced understanding of different dietary patterns and individual needs. The result is lifestyle medicine that's practical, evidence-led, and exceptional."

Darin Olien

Founder of Superlife, author, and TV host

If you want the detail.

Coming off Wegovy or Ozempic

What to expect when stopping semaglutide — appetite, weight, and what to prepare for.

Read article →

Coming off Mounjaro

A week-by-week guide to stopping tirzepatide and what happens when it clears your system.

Read article →

SSRI Withdrawal vs Relapse

How to distinguish discontinuation symptoms from returning depression. A clinical guide.

Read article →

Why GLP-1 Drugs Work Better for Some People

What genetics, dose, drug choice, and duration actually explain about variable response.

Read article →

Common Questions

Before you book.

The questions most people have before making contact.

Do you just get people off medication?

No. The review looks at indication, risk, and benefit. Sometimes the right answer is to continue, adjust, or deprescribe — case by case. The goal is the most clinically defensible decision for you, not a predetermined outcome.

How much does a consultation cost?

The GLP-1 Exit Strategy Review is £445 for a 60-minute consultation including advance review of your history and a written plan. The Metabolic and Deprescribing Review is £395. The Clinical Data Review is £295 for 45 minutes. The Independent Medication Review is £1,200 and includes two appointments and a structured written report. Follow-ups start from £125. See the full fees page →

Is this available outside Sutton Coldfield?

Yes. GLP-1 Exit Strategy Reviews and the GLP-1 Exit Programme are available by video consultation for patients across the UK. Other services are currently delivered in person at Sutton Coldfield.

How is this different from going back to my GP?

GPs manage a broad caseload under time pressure. This practice specialises specifically in deprescribing, medication review, and metabolic health — with the time and clinical focus to review your full medication history, interpret your data, and produce a written plan. It also operates independently of any commercial incentive to keep you on treatment.

Will you work with my GP or specialist?

Yes, where appropriate. A written summary goes back to your GP where clinical coordination is needed. Some plans work best in shared care.

Can I stop my medication suddenly?

No. Many medications require gradual tapering and monitoring. Never stop abruptly without clinical advice — this applies especially to SSRIs, GLP-1s, and blood pressure medication.

Is this only for GLP-1 patients?

No. GLP-1 exit is the flagship pathway, but the practice covers deprescribing across multiple medication classes — SSRIs, PPIs, statins, blood pressure medication — as well as metabolic health optimisation and clinical data review for people using private testing.

Do you prescribe medication?

Where clinically appropriate, prescriptions can be arranged via SignatureRx and delivered to your home address. The service is not a prescription shortcut — it is a clinical review that arrives at the most defensible next step.

GLP-1 Exit Strategy

Deprescribing

Independent Medication Review

Clinical Data Review

Metabolic Health

Lifestyle Medicine

High Blood Pressure

Women's HRT

Men's Hormones

After a Heart Attack

Pre-Diabetes

Normal Bloods, Feel Terrible

After Hospital

On medication and thinking about what comes next? Clinician-led plans for what happens after the prescription.

Four clinical pathways. One clinician.

GLP-1 Exit Strategy

Deprescribing

Clinical Data Review

Independent Medication Review

Choose your starting point.

GLP-1 Exit Strategy

SSRI / Antidepressant Review

PPI Review

Statin Review

Blood Pressure Medication

Levothyroxine Review

Medication Load Review

Deprescribing is the easy part.

If any of these describe you, this clinic is built for you.

GLP-1 continuation or exit

Rebound appetite and early regain

Polypharmacy & medication load

Private health data with no interpretation

High-performance and longevity focus

Family-initiated medication review

Dr Dan Reardon

Trusted by high performers.

If you want the detail.

Coming off Wegovy or Ozempic

Coming off Mounjaro

SSRI Withdrawal vs Relapse

Why GLP-1 Drugs Work Better for Some People

Before you book.

You already know something needs to change. Build the plan that makes it stick.